Related Experiment Video
Updated: Aug 4, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Genomics approaches to drug discovery
J F Reidhaar-Olson1, B K Rhees, J Hammer
1Department of Genomic and Information Sciences, Hoffmann-La Roche Inc., Nutley, New Jersey 07110-1199, USA. john.reidhaar-olson@roche.com
Journal of Cellular Biochemistry. Supplement
|February 14, 2002
Summary
Genomics and bioinformatics advances revolutionize drug discovery. This article explores genomics applications in target discovery, prodrug strategies, and vaccine development.
Area of Science:
- Genomics and Bioinformatics
- Drug Discovery and Development
Background:
- Recent advances in genomics and bioinformatics have significantly impacted drug discovery.
- The availability of genome-scale sequence data and improved analytical tools have transformed the field.
Purpose of the Study:
- To discuss the application of genomics data in drug discovery.
- To highlight three key areas: target discovery, prodrug strategies, and vaccine development.
Main Methods:
- Review of current literature and methodologies in genomics and drug discovery.
- Analysis of how genomic data is utilized in identifying drug targets.
- Examination of prodrug design and vaccine development informed by genomic insights.
Main Results:
- Genomics enables precise identification of novel drug targets.
- Genomic information facilitates the design of effective prodrug strategies.
- Genomic approaches are crucial for modern vaccine development.
Conclusions:
- Genomics and bioinformatics are integral to modern drug discovery.
- These technologies offer powerful tools for developing new therapeutics and vaccines.
Related Concept Videos
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...